Hancock Whitney’s Celgene Corp CELG Stock Holding History

Hancock Whitney’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-8,369	Closed	-$831K	–	894
2019 Q3	$831K	Sell	8,369 -94	-1%	-$8.93K	0.03%	473
2019 Q2	$782K	Sell	8,463 -749	-8%	-$71.1K	0.03%	507
2019 Q1	$869K	Buy	9,212 +262	+3%	+$22.9K	0.03%	496
2018 Q4	$573K	Sell	8,950 -6,865	-43%	-$507K	0.02%	538
2018 Q3	$1.42M	Buy	+15,815	New	+$1.4M	0.04%	410
2017 Q4	–	Sell	-6,600	Closed	-$962K	–	643
2017 Q3	$962K	Buy	+6,600	New	+$899K	0.04%	353

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Hancock Whitney's CELG Position: Q4 2019 in Review

Hancock Whitney sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,369 shares — an estimated $831K sold.

Hancock Whitney first reported a position in CELG in Q3 2017 and held it in 6 quarters. The position peaked at $1.42M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Hancock Whitney reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Hancock Whitney sold 8,369 Celgene Corp shares in Q4 2019, an estimated $831K.
Hancock Whitney first reported a position in Celgene Corp in Q3 2017 and held it in 6 quarters.
Hancock Whitney's Celgene Corp position peaked at $1.42M in Q3 2018.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Hancock Whitney's 13F filing for Q4 2019, filed 6 Feb 2020.